Brain Disease
VIDEO: ANA president discusses ‘fantastic sessions’ from annual meeting
In this video, M. Elizabeth Ross, MD, PhD, FANA, president of the American Neurological Association, spoke with Healio about some of the most memorable sessions from the ANA Annual Meeting and looks ahead to next year’s meeting.
FDA investigating hematologic cancer risk in kids treated with Skysona for brain disease
The FDA announced it is investigating serious health risks associated with administration of an autologous hematopoietic stem cell gene therapy for children with early active cerebral adrenoleukodystrophy, or CALD.
Gene therapy benefits boys with rare brain disease, but hematologic cancer remains a risk
Bluebird Bio’s lentiviral vector gene therapy Skysona met its primary efficacy endpoint of survival without major functional disability in 81% of boys with early cerebral adrenoleukodystrophy, a recent analysis showed.
AHA: Shared risk factors contribute to rising global burden of brain disease, CVD
Heart disease continues to stand as the leading global cause of death, but there has been a rapid rise in brain disease-related deaths, and risk factors for both are similar, according to an American Heart Association report.
Q&A: Controlling inflammation ‘might be key’ in neurological complications of COVID-19
Postmortem testing in a convenience sample of patients who died of COVID-19 demonstrated multifocal microvascular injury in the brain and olfactory bulbs without evidence of viral infection.